Inovio Pharmaceuticals (INO) Current Deferred Tax Assets (2012 - 2015)

Inovio Pharmaceuticals has disclosed Current Deferred Tax Assets across 4 years of filings, most recently posting $342573.0 for Q3 2015.

• In Q3 2015, Current Deferred Tax Assets rose 453.98% year-over-year to $342573.0; the TTM figure through Sep 2015 stood at $342573.0 (up 453.98% YoY), while the FY2014 annual figure was $342573.0, up 453.98% from the prior year.
• Current Deferred Tax Assets came in at $342573.0 for Q3 2015 at Inovio Pharmaceuticals, roughly flat from $342573.0 in the prior quarter.
• In the past five years, Current Deferred Tax Assets ranged from a high of $342573.0 in Q4 2014 to a low of $61839.0 in Q4 2013.
• Average Current Deferred Tax Assets over 4 years is $155713.3, with a median of $62728.0 recorded in 2012.
• Year-over-year, Current Deferred Tax Assets retreated 1.42% in 2013 and soared 453.98% in 2014.
• Over 4 years, Current Deferred Tax Assets stood at $62728.0 in 2012, then fell by 1.42% to $61839.0 in 2013, then soared by 453.98% to $342573.0 in 2014, then changed by 0.0% to $342573.0 in 2015.
• Per Business Quant data, the three most recent Current Deferred Tax Assets figures were $342573.0 in Q3 2015, $342573.0 in Q2 2015, and $342573.0 in Q1 2015.